Effects of alkalization therapy for hepatocellular carcinoma: a retrospective study

Effects of alkalization therapy for hepatocellular carcinoma: a retrospective study - Effects of alkalization therapy for hepatocellular carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049949

Enrollment

Registered

2023-01-01

Start date

2022-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with hepatocellular cancer who were treated at the Karasuma Wada Clinic between January 2013 and December 2020. Patients who received alkalization therapy. Patients who agreed written informed consent.

Exclusion criteria

Exclusion criteria: Patients who could not follow the alkalization therapy and/or visited our clinic less than 3 times.

Design outcomes

Primary

Measure	Time frame
Overall survival (OS) from diagnosis OS from the start of alkalization therapy Urine pH before and after alkalization therapy	—

Countries

Japan

Contacts

Public ContactReo Hamaguchi

Japanese Society on Inflammation and Metabolism in Cancer Japanese Society on Inflammation and Metabolism in Cancer, working group

reo-h@nifty.com+81-75-223-3223

Outcome results